Paper Review Records
全部论文审稿周期
27 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
159
天
Immune reconstitution and clinical outcomes in B-ALL patients with versus without pre-HSCT Immunotherapy
作者
Yu-Yuan Zeng; Guan-Hua Hu; Ying-Xi Zuo; Pan Suo; Lu Bai; Feng Zhang; Hui-Fang Wang; Ying-Jun Chang; Meng Lv; Xiao-Hui Zhang; Yu Wang; Lan-Ping Xu; Xiao-Jun Huang; Lin Wang; Yi-Fei Cheng展开收起
作者单位
1. Department of Child Health Care, Capital Center for Children’s Health, Capital Medical University, Beijing, China; 2. Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking-Tsinghua Center for Life Science, Research Unit of Key Technique for Diagnosis and Treatment of Hematologic Malignancies, Chinese Academic of Medical Sciences, Beijing, China展开收起
148
天
Final analysis results from DREAMM-3, a phase 3 study of belantamab mafodotin versus pomalidomide plus dexamethasone in patients with relapsed/refractory multiple myeloma
作者
Meletios Athanasios Dimopoulos; Vania Hungria; Haitao Meng; Atanas Radinoff; Jian Li; Sosana Delimpasi; Ting Niu; Gabor Mikala; Tamas Masszi; Marcelo Capra; Michael Low; Angelo Maiolino; Yan Xu; Xavier Leleu; Vasiliki Pappa; Dominik Chraniuk; Tatiana Konstantinova; Iurii Osipov; Shawn Hakim; Chris Brawley; Gabriela Tubel; Astrid McKeown; Julia Boyle; Sumita Roy-Ghanta; Katja Weisel展开收起
作者单位
1. National and Kapodistrian University of Athens, Athens, Greece; 2. Korea University, Seoul, South Korea; 3. Department of Hematology, Clinica São Germano São Paulo, São Paulo, Brazil; 4. The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; 5. University Hospital “St Ivan Rilski” EAD, Sofia, Bulgaria; 6. Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People’s Republic of China; 7. General Hospital Evangelismos, Athens, Greece; 8. West China Hospital of Sichuan University, Chengdu, China; 9. South Pest Central Hospital, National Institute for Haematology and Infectious Diseases, Budapest, Hungary; 10. Semmelweis University Department of Internal Medicine and Hematology, Budapest, Hungary; 11. Centro Gaúcho Integrado de Pesquisa, Hospital Mãe de Deus, Porto Alegre, Brazil; 12. Monash Haematology, Monash University, Clayton University, Victoria, Australia; 13. Instituto Americas de Ensino, Pesquisa e Inovacao, Rio de Janeiro, Brazil; 14. Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil; 15. Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences, Tianjin, China; 16. Hospital of Poitiers, Poitiers, France; 17. Second Department of Internal Medicine and Research Unit, Hematology Unit, University General Hospital “Attikon”, Athens, Greece; 18. Department of Hematology, Wojewodzki Szpital Zespolony, Torun, Poland; 19. Regional Clinical Hospital No 1, Ekaterinburg, Russian Federation; 20. V.A. Almazov National Medical Research Centre, Saint-Petersburg, Russian Federation; 21. GSK, Upper Providence, USA; 22. GSK, London, UK; 23. GSK, Stevenage, UK; 24. University Medical Center of Hamburg-Eppendorf, Hamburg, Germany展开收起
79
天
Improving survival and narrowing age disparities in mantle cell lymphoma across therapeutic eras
作者
Malak Munir; John L. Vaughn; Sravani Rimmalapudi; Narendranath Epperla展开收起
作者单位
1. Department of Medicine, Rochester General Hospital, Rochester, USA; 2. Division of Hematology & Oncology, Westchester Medical Center, Valhalla, USA; 3. Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, USA展开收起
128
天
Glucagon-like peptide-1 receptor agonists and risk for hematologic malignancies: a multicenter propensity score-matched analysis
作者
Pratik Shah; Adit Singhal; Tsu Hsien Wang; Albert Ko; Yu-Cheng Chang; Anita Ng; Andrew Shih; Yuan Ping Hsia; Cho-Hung Chiang; Cho-Han Chiang展开收起
作者单位
1. Northwell Health Cancer Institute, Lake Success, USA; 2. Department of Medicine, University at Buffalo-Catholic Health System, Buffalo, USA; 3. Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, USA; 4. Department of Medicine, Danbury Hospital, Danbury, USA; 5. Feinstein Institutes for Medical Research, Manhasset, USA; 6. Department of Family Medicine, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan; 7. Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan展开收起
114
天
A structural framework for mutation-guided immunotherapy sequencing of GPRC5D-targeted T cell engagers in multiple myeloma
作者
Ricardo Ahrens; Kyra Ahrens; Maximilian Al-Bazaz; Lisa Leypoldt; Carsten Bokemeyer; Winfried Alsdorf; Katja Weisel展开收起
作者单位
1. Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; 2. Knowledge Technology Group, Department of Informatics, University of Hamburg, Hamburg, Germany展开收起
79
天
Clinicomolecular features and clonal evolution of KMT2A -PTD AML: prognostic impact of concurrent FLT3 -ITD under 2022 ELN risk stratification
作者
Yi-Tsung Yang; Chi-Yuan Yao; Yong-Huai Yi; Chein-Jun Kao; Yuan-Yeh Kuo; Ming-En Lin; Hsin-An Hou; Chien-Chin Lin; Wen-Chien Chou; Hwei-Fang Tien展开收起
作者单位
1. Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; 2. Department of Internal Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan; 3. Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital Yunlin Branch, Yunlin, Taiwan; 4. Tai-Chen Cell Therapy Center, National Taiwan University, Taipei, Taiwan; 5. Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan; 6. Department of Internal Medicine, Far-Eastern Memorial Hospital, New Taipei City, Taiwan展开收起
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
